Morgan Stanley Raises iRhythm (IRTC) PT on MedTech Recovery Outlook

iRhythm Technologies, Inc. (NASDAQ:IRTC) is one of the best healthcare AI stocks to buy now. On December 2, Morgan Stanley raised its price target on iRhythm Technologies, Inc. (NASDAQ:IRTC) from $195 to $205, while maintaining an Overweight rating. The adjustment comes as part of a broader positive preview for the MedTech industry heading into 2026. Morgan Stanley said it sees the industry as well-positioned on several fronts. Some of the key drivers cited include major product cycles across the space, a ...